14-103698914-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_005432.4(XRCC3):c.925G>A(p.Gly309Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000127 in 1,600,418 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Consequence
NM_005432.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XRCC3 | NM_005432.4 | c.925G>A | p.Gly309Ser | missense_variant | 10/10 | ENST00000555055.6 | NP_005423.1 | |
KLC1 | NM_001394837.1 | c.1849-1741C>T | intron_variant | ENST00000334553.11 | NP_001381766.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XRCC3 | ENST00000555055.6 | c.925G>A | p.Gly309Ser | missense_variant | 10/10 | 1 | NM_005432.4 | ENSP00000452598 | P1 | |
KLC1 | ENST00000334553.11 | c.1849-1741C>T | intron_variant | 5 | NM_001394837.1 | ENSP00000334523 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000284 AC: 63AN: 222118Hom.: 0 AF XY: 0.000364 AC XY: 44AN XY: 120878
GnomAD4 exome AF: 0.000133 AC: 193AN: 1448132Hom.: 0 Cov.: 31 AF XY: 0.000195 AC XY: 140AN XY: 719168
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152286Hom.: 0 Cov.: 33 AF XY: 0.0000806 AC XY: 6AN XY: 74458
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The XRCC3 p.Gly309Ser variant was not identified in the literature nor was it identified in ClinVar. The variant was identified in dbSNP (ID: rs532124840) and in control databases in 65 of 253456 chromosomes at a frequency of 0.0002565 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: South Asian in 59 of 28102 chromosomes (freq: 0.002099), East Asian in 3 of 18218 chromosomes (freq: 0.000165), Other in 1 of 6638 chromosomes (freq: 0.000151) and European (non-Finnish) in 2 of 113534 chromosomes (freq: 0.000018), but was not observed in the African, Latino, Ashkenazi Jewish, or European (Finnish) populations. The p.Gly309 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and 2 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Ovarian cancer Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory of Molecular Epidemiology of Birth Defects, West China Second University Hospital, Sichuan University | Jan 01, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at